Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lemborexant in Delayed Sleep Phase Syndrome

NCT06874855 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT06874855
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06874855 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lemborexant in Delayed Sleep Phase Syndrome
Lead sponsor
University of California, San Francisco
Phase
Phase 4
Overall status
Recruiting
Start date
March 13, 2023
Completion date
May 31, 2027
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

delayed sleep phase syndrome